Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma

General Thoracic and Cardiovascular Surgery

Volumn 57, Issue 11, 2009, Pages 585-590

  Okubo, Kenichi ^a   Sonobe, Makoto ^a   Fujinaga, Takuji ^a   Shoji, Tsuyoshi ^a   Sakai, Hiroaki ^a   Miyahara, Ryo ^a   Bando, Toru ^a   Date, Hiroshi ^a   Shibuya, Keiko ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chemotherapy; Extrapleural pneumonectomy; Malignant pleural mesothelioma; Radiation therapy; Trimodality therapy

Indexed keywords

CATECHOLAMINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; PEMETREXED;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFUSION; DISTANT METASTASIS; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GRANULOCYTOPENIA; HEART FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LUNG RESECTION; MALE; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PROGNOSIS; SARCOMA; SURVIVAL RATE; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MESOTHELIAL; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TREATMENT OUTCOME;

EID: 73349096645     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-009-0440-2     Document Type: Article

References (25)

1. M.R. Law M.E. Hodson M. Turner-Warwick 1984 Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment Eur Respir J Suppl 65 162 168 1:STN:280:DyaL2c3gvVCmtQ%3D%3D
2. P. Ruffie R. Feld S. Minkin Y. Cormier A. Boutan-Laroze R. Ginsberg, et al. 1989 Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients J Clin Oncol 7 1157 1168 1:STN:280:DyaL1MzivVCqtg%3D%3D 2666592
3. N.J. Vogelzang J.J. Rusthoven J. Symanowski C. Denham E. Kaukel P. Ruffie, et al. 2003 Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2636 2644 10.1200/JCO.2003.11.136 1:CAS:528:DC%2BD2cXptlCktL4%3D 12860938 (Pubitemid 46606305)
4. Statistics and Information Department of Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital Statistics of Japan 2006, Vol III. p. C45, 140.
5. D.J. Sugarbaker R.M. Flores M.T. Jaklitsch W.G. Richards G.M. Strauss J.M. Corson, et al. 1999 Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 54 65 10.1016/S0022-5223(99)70469-1 1:STN:280:DyaK1M7gt1Ghug%3D%3D 9869758 (Pubitemid 29022249)
6. G. Maggi C. Casadio R. Cianci O. Rena E. Ruffini 2001 Trimodality management of malignant pleural mesothelioma Eur J Cardiothorac Surg 19 346 350 10.1016/S1010-7940(01)00594-2 1:STN:280:DC%2BD3MzjvFGnsQ%3D%3D 11251277 (Pubitemid 32197443)
7. V.W. Rusch K. Rosenzweig E. Venkatraman L. Leon A. Raben L. Harrison, et al. 2001 A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J Thorac Cardiovasc Surg 122 788 795 10.1067/mtc.2001.116560 1:STN:280:DC%2BD3MrjsVektQ%3D%3D 11581615 (Pubitemid 35470127)
8. T. Aziz A. Jilaihawi D. Prakash 2002 The management of malignant pleural mesothelioma: single centre experience in 10 years Eur J Cardiothorac Surg 22 298 305 10.1016/S1010-7940(02)00273-7 12142203 (Pubitemid 34831874)
9. V.W. Rusch 1995 A proposed new international TNM staging system for malignant pleural mesothelioma. From the Inter national Mesothelioma Interest Group Chest 108 1122 1128 10.1378/chest.108.4.1122 1:STN:280: DyaK28%2FhtVWktA%3D%3D 7555126
10. A. Trotti A.D. Colevas A. Setser V. Rusch D. Jaques V. Budach, et al. 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 176 181 10.1016/S1053-4296(03) 00031-6 12903007 (Pubitemid 36962641)
11. K. Takagi R. Tsuchiya Y. Watanabe 2001 Surgical approach to pleural diffuse mesothelioma in Japan Lung Cancer 31 57 65 10.1016/S0169-5002(00)00152-5 1:STN:280:DC%2BD3M7ns1ykug%3D%3D 11162867 (Pubitemid 32012603)
12. M. Higashiyama K. Morinaga 2007 Survey of surgical treatment of malignant pleural mesothelioma in Japan Kyobu Geka 60 19 24 1:STN:280: DC%2BD2s%2FkslSiug%3D%3D 17249533
13. S. Hasegawa F. Tanaka M. Okada K. Nakano 2008 Current status of muitimodality treatment for malignant pleural mesothelioma in Japan Jpn J Lung Cancer 48 93 96 10.2482/haigan.48.93 (Pubitemid 351754062)
14. A. Ahamad C.W. Stevens W.R. Smythe Z. Liao A.A. Vaporciyan D. Rice, et al. 2003 Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest Cancer J 9 476 484 10.1097/00130404-200311000-00008 14740977
15. D.J. Stewart A. Martin-Uncar J.E. Pilling J.G. Edwards K.J. O'Byrne D. Waller 2004 The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma Ann Thorac Surg 78 245 252 10.1016/j.athoracsur.2004.01.034 15223437 (Pubitemid 38833940)
16. W. Weder P. Kestenholz C. Taverna S. Bodis D. Lardinois M. Jerman, et al. 2004 Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma J Clin Oncol 22 3451 3457 10.1200/JCO.2004.10.071 1:CAS:528:DC%2BD2cXpsVWkur0%3D 15337794 (Pubitemid 41103650)
17. M.J. Byrne J.A. Davidson A.W. Musk J. Dewar G. van Hazel M. Buck, et al. 1999 Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study J Clin Oncol 17 25 30 1:CAS:528:DyaK1MXltVyksA%3D%3D 10458214
18. A.K. Nowak M.J. Byrne R. Williamson G. Ryan A. Segal D. Fielding, et al. 2002 A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma Br J Cancer 87 491 496 10.1038/sj.bjc.6600505 1:CAS:528: DC%2BD38Xmt12qurg%3D 12189542 (Pubitemid 35052715)
19. V.W. Rusch 1993 Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma Chest 103 382S 384S 10.1378/chest.103.4-Supplement.382S 1:STN:280:DyaK3s3hsFehsQ%3D%3D 8462330
20. W. Gordon K.H. Antman J.S. Greenberger R.R. Weichselbaum J.T. Chaffey 1982 Radiation therapy in the management of patients with mesothelioma Int J Radiat Oncol Biol Phys 8 19 25 6174494
21. E.H. Baldini A. Recht G.M. Strauss M.M. DeCamp Jr S.J. Swanson M.J. Liptay, et al. 1997 Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann Thorac Surg 63 334 338 10.1016/S0003-4975(96)01228-3 1:STN:280:DyaK2s7osFKitw%3D%3D 9033296 (Pubitemid 27084548)
22. A. Ahamad C.W. Stevens W.R. Smythe A.A. Vaporciyan R. Komaki J.F. Kelly, et al. 2003 Intensity modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 55 768 775 12573764
23. D.C. Rice C.S. Stevens A.M. Correa A.A. Vaporciyan A. Tsao K.M. Forster, et al. 2007 Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma Ann Thorac Surg 84 1685 1693 10.1016/j.athoracsur.2007.04.076 17954086 (Pubitemid 47588107)
24. A.M. Allen M. Czerminska P.A. Jänne D.J. Sugarbaker R. Bueno J.R. Harris, et al. 2006 Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma Int J Radiat Oncol Biol Phys 65 640 645 16751058
25. A.M. Allen D. Schofield F. Hacker L.E. Court M. Czerminska 2007 Restricted field IMRT dramatically enhances IMRT planning for mesothelioma Int J Radiat Oncol Biol Phys 69 1587 1592 17892915